IP
Longevity research is on the rise with Genflow latest to file for patent
June 10 by Leila HawkinsGenflow has filed a patent application for anti-aging therapies
Keeping tabs on Covid-19: Debate intensifies over Covid-19 vaccine patent waiver
May 14 by Emily UwemedimoChina and the US back vaccine waiver to help India’s Covid-19 crisis, while the UK and EU remain skeptical despite a willingness to discuss the proposal
Keeping tabs on Covid-19: Moderna eliminates its IP barriers for vaccine development and Israeli manufacturing facility committed to support supply of EU vaccines
October 09 by Emily UwemedimoDiscover the latest solutions on offer from Moderna and Mapi Pharma to support the global efforts to provide Covid-19 vaccinations
Top Five Global Patent Concerns for 2015
August 19 by Pharmaceuticals & Biotechnology EditorIP professionals are constantly being pulled in different directions. In today’s global markets, it is crucial to understand international legal frameworks across a wide range of di...
Less Risk, More Reward in IP
August 03 by Pharmaceuticals & Biotechnology EditorRead this paper to explore the drivers shaping the re-evaluation of IP in the research and development sector and the technical features that make a platform like E-WorkBook a particularly suitable...
Modernising IP law - the IP bill
June 13 by Pharma IQ NewsPartner Will Cook from Marks & Clerk Solicitors comments "In its current form, the new Bill will amend the Patents Act 1977 to give powers to bring the Unitary Patent Court Agreement into...
Record Patent Filings “Encouraging News” for UK Business
March 07 by Pharma IQ News- Comment from Intellectual Property Specialists Marks & Clerk on 2012 patent filing statistics released by European Patent Office - Statistics from the Annual Report of European Patent Office...
Clinical Research “Likely to Return to the UK” Following Change in Patent Law
February 26 by Cold Chain IQ NewsComment from Intellectual Property specialists Marks & Clerk on the Government decision to exempt clinical and field trials from patent infringement - The UK Government has today announced pla...
Schutz sensibler Informationen in der Life Sciences Branche
January 12 by Pharmaceuticals & Biotechnology EditorThis whitepaper from Brainloop is an excellent reading companion to their Intellectual Property Protection Webinar. As any Out-licensing project manager will testify, protecting your intellectual...
Intellectual Property Protection Solutions for Pharma and Biotech - Part 2
November 10 by Pharma IQIn part one of our Brainloop interview we introduced BrigitteEhret, Director at Brainloop who explained some of the questions pharma professionals have about IP protection when partnerships demand d...
Don’t Lose Your Intellectual Property
October 15 by Andrea CharlesIn this Pharma IQ podcast David Topping, Vice President Global Marketing, Brainloop, and Andrea Charles from Pharma IQ, discuss what is out-licensing and the steps companies need to take to pro...
Ensuring Information Protection in the Electronic Communication Age
October 15 by Amber ScorahIn today's age of electronic communication, the ability to properly protect, monitor and disseminate information being transferred becomes more difficult. In this podcast, Joseph Mariano, a Reco...